No Data
April 28th [Today's Investment Strategy]
[Fisco Selected Stocks]【Material Stocks】Hokkan Holdings <5902> 1,699 yen (4/25) Engaged in food cans, PET bottles, and filling business. The profit forecast for the fiscal year ending March 2025 has been revised upward. The estimated operating profit is 4.5 billion yen (up 2.5% from the previous year). This is an upward revision of about 9% from the previous financial estimates, resulting in a projected increase in profit. Revenue is expected to be lower than the previous forecast, but due to cost reductions in factory expenses and Logistics costs, profit has been upwardly revised. The year-end Dividends have been set at 70 yen.
Astellas Pharma and Hokkan Holdings are in the spotlight, while Nitto Denko and Yamazaki Baking seem to be underperforming.
Last weekend on the 25th, in the US Stocks market, the Dow Jones Industrial Average rose by 20.10 points to 40,113.50, the Nasdaq Composite Index increased by 216.90 points to 17,382.94, and the Chicago Nikkei 225 Futures were up by 220 yen compared to the Osaka daytime at 36,000 yen. The exchange rate was 1 dollar = 143.70-80 yen. In today's Tokyo market, Astellas Pharma <4503>, which experienced a significant increase in operating profit for the fiscal year ending March 2025, at 60.8% growth from a previous financial estimate of a 56.9% decline.
Japan Post, upward revision on March 25, ordinary profit 810 billion yen, down from 760 billion yen.
Japan Post <6178> announced a revision of its financial estimates for the fiscal year ending March 2025. The ordinary profit was revised upwards from 760 billion yen to 810 billion yen. While the profit estimates for the five postal banks <7182> and Japan Post Insurance <7181> will be revised upwards in November 2024 due to improved operating conditions and increased Asset Management revenue, the consolidated financial estimates for the full year are uncertain, particularly regarding the impact on future profits and losses from the upcoming postal rate revision at its consolidated subsidiary, Japan Post.
Astellas Pharma Inc. (ALPMF) Q4 2024 Earnings Call Transcript Summary
Astellas Pharma To Go Ex-Dividend On March 30th, 2026 With 39 JPY Dividend Per Share
April 26th (Japan Standard Time) - $Astellas Pharma(4503.JP)$ is trading ex-dividend on March 30th, 2026.Shareholders of record on March 31st, 2026 will receive 39 JPY dividend per share. The ex-
Astellas Pharma To Go Ex-Dividend On September 29th, 2025 With 39 JPY Dividend Per Share
April 26th (Japan Standard Time) - $Astellas Pharma(4503.JP)$ is trading ex-dividend on September 29th, 2025.Shareholders of record on September 30th, 2025 will receive 39 JPY dividend per share.
